急性B型主动脉壁内血肿:随访CT的附加预后价值
本回顾性汇总分析纳入238例初始药物治疗的B型主动脉壁内血肿患者,评估基线与随访CT特征的预后意义。随访CT新发溃疡样突起、最大血肿厚度变化及新发胸腔积液等为不良主动脉相关事件的独立预测因素,随访CT可提供增量预后信息。
要点
- 随访CT新发溃疡样突起(HR=4.44)是新发溃疡样突起对不良主动脉相关事件预测最强的独立因素。
- 基线最大血肿厚度≥11.8 mm、溃疡样突起及随访CT新发溃疡样突起、新发胸腔积液为1个月主动脉事件独立预测因素。
- 基线有胸腔积液者,胸腔积液吸收与较低的不良事件风险相关(HR=0.36)。
核心结论
- 随访CT所见可为初始药物治疗的B型主动脉壁内血肿提供有力且增量的预后信息,有助于风险评估和决策。
研究设计与样本
- 回顾性汇总分析个体患者数据,纳入238例初始药物治疗的B型主动脉壁内血肿患者,平均年龄58.1±9.8岁,男性73.9%,分析基线与随访CT特征,随访终点为主动脉疾病相关死亡和外科或血管内主动脉修复的复合不良主动脉相关事件。
关键影像表现/征象
- 随访CT新发溃疡样突起(HR=4.44,p<0.001)和新发胸腔积液(HR=2.46,p=0.002)为不良主动脉相关事件的独立预测因素。
- 最大血肿厚度变化(HR=1.22,p<0.001)和基线最大主动脉直径(HR=1.05,p=0.008)亦为独立预测因素。
- 基线有胸腔积液者,胸腔积液吸收与不良主动脉相关事件风险降低相关(HR=0.36,p=0.027)。
诊断标准与关键数值
- 预测不良主动脉相关事件的Cox回归模型:基线最大主动脉直径HR=1.05(p=0.008)、溃疡样突起HR=2.47(p<0.001)、最大血肿厚度变化HR=1.22(p<0.001)、新发溃疡样突起HR=4.44(p<0.001)、新发胸腔积液HR=2.46(p=0.002)。
- 预测1个月主动脉事件的联合模型:基线最大血肿厚度≥11.8 mm(OR=4.39,p=0.001)、溃疡样突起(OR=3.98,p<0.001)、最大血肿厚度变化(OR=1.46,p<0.001)、新发溃疡样突起(OR=9.27,p=0.002)、新发胸腔积液(OR=3.45,p=0.015)。
- 基线有胸腔积液者,胸腔积液吸收与1个月主动脉事件风险降低相关(OR=0.23,p=0.026)。
临床应用与阅片要点
- 对未接受紧急有创治疗的B型主动脉壁内血肿患者,高度推荐进行随访CT检查。
- 随访CT新发溃疡样突起或新发胸腔积液提示不良主动脉相关事件风险较高。
- 基线存在胸腔积液者,随访CT显示胸腔积液吸收可能提示风险较低。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To investigate prognostic significance of follow-up CT findings for initially medically treated type B aortic intramural hematoma (IMH).
METHODS: We performed a retrospective pooled analysis of individual patient data, including baseline and follow-up CT characteristics. All enrolled patients were followed up for adverse aorta-related events, defined as a composite of aortic disease-related death and surgical or endovascular aortic repair.
RESULTS: A total of 238 patients (73.9% men) were included, with a mean age of 58.1 ± 9.8 years. During follow-up, 83 patients (34.9%) experienced adverse aorta-related events, most of the events (83.1%) occurred within 1 month after follow-up CT imaging (n = 69). In the Cox regression model for predicting adverse aorta-related events, baseline maximal aortic diameter (MAD) (HR = 1.05, p = 0.008), ulcer-like projection (ULP) (HR = 2.47, p < 0.001), changes of maximal hematoma thickness (MHT) (HR = 1.22, p < 0.001), newly developed ULP (HR = 4.44, p < 0.001), and newly developed pleural effusion (HR = 2.46, p = 0.002) were powerful independent predictors. In combined predictive model for 1-month aortic events, baseline MHT ≥ 11.8 mm (OR = 4.39, p = 0.001), ULP (OR = 3.98, p < 0.001), changes of MHT (OR = 1.46, p < 0.001), newly developed ULP (OR = 9.27, p = 0.002), and newly developed pleural effusion (OR = 3.45, p = 0.015) were independent predictors. Besides, in patients with pleural effusion at baseline, resorption of pleural effusion was associated with adverse aorta-related events (HR = 0.36, p = 0.027) and 1-month aortic events (OR = 0.23, p = 0.026).
CONCLUSIONS: Follow-up CT findings provide strong and incremental prognostic information for initially medically treated type B IMH, which are helpful for risk estimates and decisions-making.
KEY POINTS: • Follow-up CT provides strong and incremental prognostic information for initially medically treated type B aortic intramural hematoma. • Follow-up CT is highly recommended for type B intramural hematoma in patients who did not receive urgent invasive therapy. • Follow-up CT is helpful for risk estimates and decisions-making.
引用
- Li Z, Lu B, Chen Y, et al. Acute type B aortic intramural hematoma: the added prognostic value of a follow-up CT. Eur Radiol. 2019. PMID: 31144073. doi:10.1007/s00330-019-06254-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。